Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

NYON, Switzerland, August 25 /PRNewswire/ -- Mymetics Corporation (OTC: MYMX), will be holding an important conference call on Wednesday August 27th 2008 at 1 PM New York Time to update all shareholders on the recent progress of the company, the June 30th 2008 Form 10-Q and to address recent press articles.

You may join the call Toll Free from the US at +1-866-591-4361 PIN 815 726 and from Europe at +41-800-329-326 PIN 815 726.

Corporate description:

HAMBURG, Germany, August 25 /PRNewswire/ --

- Cremer Care Ensures European Distribution-Rights for the Cosmetics Raw Materials Organic Glycerine and Soap-Noodles

Since July, 1st, 2008 Cremer Care has become the exclusive distributor of organic products from the renowned Daabon group of Colombia for the European cosmetics market. A long tradition in bio-production and the special social commitment of the South-American producer fits perfectly with the principles of the North German supplier of cosmetics ingredients - expressed in Cremer Care's motto 'Inspired By Nature'.

COPENHAGEN, Denmark, August 25 /PRNewswire/ --

- Front Line CLL, NHL and CLL Retreatment and Japanese Development Studies Planned

Genmab has announced plans to begin four studies of ofatumumab in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

Genmab A/S (OMX: GEN) announced today plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year.

HOUSTON, August 25 /PRNewswire/ --

Endeavour International Corporation (Amex: END) (LSE: ENDV) announced today that Barry J. Galt, a member of the board of directors, died on August 22, 2008. Galt served as a director of the corporation since 2004 when Endeavour was first established as a North Sea-focused oil and gas exploration and production company.

SALT LAKE CITY, August 25 /PRNewswire/ --

- New IT Services Company Makes First Acquisition; Delivers Software, Hardware and Consulting Services to Companies with Up to 5000 Users

Founders Steve DeWindt and Dave Taylor, in conjunction with vSpring Capital, today announced the formation of Sparxent, Inc., which was established to provide software, hardware and IT consulting services to mid-market customers. Sparxent also announced that it acquired NetworkD Corporation of Newport Beach, California and has signed a letter of intent to acquire Arbyte of Moscow.

SALT LAKE CITY, August 25 /PRNewswire/ --

- NetworkD Becomes Part of Company Focused on Providing Software, Hardware and IT Consulting Services to Mid-Market Customers

Sparxent, a newly formed IT and business solution provider focused on the middle market, today announced it completed the acquisition of NetworkD Corporation, a value-added reseller based in Newport Beach, Calif., with offices in North America and Europe. Exact financial terms of the transaction were not disclosed.